Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

SELL
$23.07 - $32.77 $5,536 - $7,864
-240 Reduced 2.68%
8,700 $244,000
Q4 2022

Feb 09, 2023

BUY
$25.29 - $35.48 $226,092 - $317,191
8,940 New
8,940 $226,000
Q3 2022

Nov 07, 2022

SELL
$24.0 - $33.42 $7,200 - $10,026
-300 Reduced 3.25%
8,940 $257,000
Q2 2022

Aug 08, 2022

BUY
$24.78 - $33.36 $228,967 - $308,246
9,240 New
9,240 $234,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Moors & Cabot, Inc. Portfolio

Follow Moors & Cabot, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.